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Opinion paper
This Spe cial re po rt is bei ng si mul ta neuos ly pub lis-
hed in 2010/2011 in Bioc he mia Me di ca, Dia be to lo-
gia Croa ti ca and croa tia n-tran sla ted ver sion in Li-
ječ nič ki vjes nik. Co pyi ng wi th at tri bu tion al lowed 
for on ly no n-com mer cial use of wo rk.
Lo ng-te rm con tro ver sies re gar di ng he mog lo bin 
A1c (HbA1c) stan dar di za tion seem to ha ve fi  nal ly 
reac hed the glo bal con sen sus poi nt. He mog lo bin 
A1c, an in teg ra ted mea su re of glycae mic con trol, 
has been wi de ly used as a „go ld-stan da rd” in ma-
na ge me nt of dia be tes mel li tus for de ca des (1). 
Howe ver, the stan dar di za tion of the „go ld-stan da-
rd” has been ve ry diffi   cu lt to ac hie ve, due to so far 
unpre ce den ted con fl i ct be tween ana lyti cal and 
cli ni cal stan dar di za tion con ce pt.
Ever sin ce the re sul ts of the Dia be tes Con trol and 
Com pli ca tion Trial (DCCT) showed po si ti ve re la-
tion ship be tween the deg ree of glycae mic con trol 
(as ses sed as he mog lo bin A1c) and ri sk for de ve lop-
me nt of dia be tic com pli ca tio ns, the goal for suc-
ces sful dia be tes treat me nt has been an cho red to 
the he mog lo bin A1c le vel <7% (2). Howe ver, the 7% 
cu t-o ff  has been de ri ved from DCCT da ta by usi ng 
hig hly rep ro du cib le, but no n-spe ci fi c HPLC met-
hod for he mog lo bin A1c mea su re me nt. Ba sed on 
the „DCCT-met hod”, the Na tio nal Glyco he mog lo-
bin Stan dar di za tion Prog ram me (NGSP) has been 
de sig ned to har mo ni ze re sul ts from all the met ho-
ds to the DCCT-tra ceab le re sul ts. Thus, a cli ni cal 
har mo ni za tion has been ac hie ved and all the re-
sul ts obtai ned by the NGSP-tra ceab le met ho ds 
cou ld ea si ly be com pa red to the glo bal ly ac cep ted 
cli ni cal goa ls for glycae mic con trol (3).
In the mean ti me, In ter na tio nal Fe de ra tion of Cli ni-
cal Che mis try (IFCC) de ve lo ped pri ma ry re fe ren ce 
stan da rd and re fe ren ce met hod, whi ch has been 
ac cep ted as the on ly va lid an chor to ca lib ra te he-
mog lo bin A1c met ho ds wor ldwi de (4). Howe ver, 
due to its spe ci fi  ci ty, IFCC re fe ren ce met hod ma-
na ged to pro du ce sig ni fi  can tly lower he mog lo bin 
A1c re sul ts than DCCT-HPLC met hod (5). This was 
fou nd to be unac cep tab ly con fu si ng for the me di-
cal dia be to lo gy com mu ni ty, mos tly be cau se of the 
evi den ce that lowe ri ng the he mog lo bin A1c ran ge 
and, con sequen tly, glycae mic goa ls, cou ld ha ve 
psycho lo gi cal im pa ct to the pa tien ts and lead to 
the wor se ni ng of glycae mic con trol (6).
In or der to over co me this prob lem, IFCC pro po sed 
to swit ch re por ti ng uni ts from con ven tio nal (%) to 
the SI uni ts (mmol/mol) (6), whi ch fi  nal ly re sul ted 
in to „2010 Con sen sus Sta te me nt on the Wor ldwi-
de Stan da ri za tion of the He mog lo bin A1c Mea su re-
me nt” (7). The con sen sus was ag reed be tween 
Ame ri can Dia be tes As so cia tion (ADA), Eu ro pean 
As so cia tion for the Stu dy of Dia be tes (EASD), In ter-
na tio nal Dia ba tes Fe de ra tion (IDF), IFCC and In ter-
na tio nal So cie ty for the Pe diat ric and Ado les ce nt 
Dia be tes (ISPAD) du ri ng the I DF-Wor ld Dia be tes 
Con gre ss in Mon treal, Ca na da, Oc to ber 2009.
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Con sen sus sta te me nt im pli ca tes glo bal stan dar di-
za tion of he mog lo bin A1c ac cor di ng to the IFCC re-
fe ren ce system, and pro po ses dual system of he-
mog lo bin A1c re por ti ng by cli ni cal la bo ra to ries 
wor ldwi de: SI (mmol/mol, no de ci ma ls) and con-
ven tio nal (%, NGSP-de ri ved, one de ci mal). Con ver-
sion be tween uni ts shou ld be do ne by usi ng IFCC-
NGSP mas te r-equa tion, and con ver sion tab les 
shou ld be avai lab le to the me di cal and lay par ts of 
dia be tic com mu ni ty. The re por tab le te rm is HbA1c. 
As re gar ds pub lis hi ng, the re is a stro ng re com-
men da tion to the edi to rs of me di cal jour na ls to 
requi re dual system of re por ti ng in all ma nus crip ts 
re por ti ng HbA1c re sul ts.
The con sen sus shou ld be im ple men ted as soon as 
pos sib le wor ldwi de, wi th con cer ted eff or ts of la-
bo ra to ry and me di cal pro fes sio na ls in tran sfer ri ng 
all ne ces sa ry in for ma tion wit hin the dia be tes com-
mu ni ty. Fur ther ste ps in glo bal stan dar di za tion of 
he mog lo bin A1c sha ll be pro po sed on the next 
con sen sus mee ti ng, at the IDF Wor ld Dia be tes 
Con gres in Du bai, De cem ber 2011.
The im ple men ta tion of the glo bal con sen sus in 
Croa tia is plan ned as a 4-step pro ce ss:
1. Croa tian Cham ber of Me di cal Bioc he mis ts has 
an noun ced on its we b-pa ges ac ti vi ties re gar-
di ng con sen sus im ple men ta tion, to get her wi th 
tran sla ted con sen sus sum ma ry (Oc to ber 2010).
2. Croa tian So cie ty of Me di cal Bioc he mis try, as 
the na tio nal EQA S-or ga ni zer, has pre pa red ne-
ces sa ry mo di fi ca tio ns in the HbA1c pa rt of the 
sche me, whi ch sha ll be exe cu ted wi th the 3rd 
an nual EQA-cycle in No vem ber 2010. Brief ly, all 
the par ti ci pan ts sha ll be as ked to pro vi de re-
sul ts expres sed in dual re por ti ng system, and 
ma ke all the ne ces sa ry ar ran ge men ts for the 
rou ti ne con sen sus im ple men ta tion (De cem ber 
2010). It shou ld be men tio ned that con sen sus 
im ple men ta tion requi res on ly a mat he ma ti cal 
ope ra tion, and no ad di tio nal expen ses to the 
HbA1c tes ti ng are to be expec ted. Rea ge nt ma-
nu fac tu re rs ha ve al rea dy pre pa red all the ne-
ces sa ry NGSP-con ver sion for mu la de tai ls.
3. Dual re por ti ng of HbA1c re sul ts from all la bo-
ra to ries in Croa tia shou ld be ope ra ti ve as from 
Ja nua ry 1st 2011. Croa tian Cham be rs of Me di cal 
Bioc he mis ts sha ll pre pa re a let ter of in for ma-
tion, ad dres sed to all re le va nt par tne rs in the 
dia be tes com mu ni ty (Ja nua ry 2011).
4. A spe cial re po rt co ve ri ng this is sue wi ll be pub-
lis hed in re le va nt scien ti fic jour na ls: Bioc he mia 
Me di ca, Dia be to lo gia Croa ti ca, and tran sla ted 
ver sion in Li ječ nič ki vjes nik.
We ho pe that this pro ce ss wi ll en su re ne ces sa ry 
con di tio ns for suc ces sful im ple men ta tion of the 
glo bal con sen sus to the Croa tian me di cal and la-
bo ra to ry com mu ni ty in vol ved in dia be tes ca re.
Con si de ri ng ri si ng pre va len ce of dia be tes mel li tus 
in Croa tia (8), com plian ce to the glo bal con sen sus 
not on ly pro vi des har mo ni za tion of he mog lo bin 
A1c re por ti ng, but al so as su res the con ti nui ty of im-
ple men ta tion of the hig he st stan dar ds of me di cal 
ca re for dia be tic pa tien ts in Croa tia.
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